微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 31.2% | 5.26% | -4.52% | 110/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 32.67% | 7.07% | 14.2% | 104/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 28.61% | -0.61% | -4.48% | 110/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 29.95% | 7.01% | 1.07% | 112/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 29.64% | 2.83% | -2.89% | 112/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 30.52% | 6.02% | 6.02% | 109/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 28.78% | 3.23% | 2.83% | 113/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 27.99% | -5.98% | -2.88% | 110/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 28.82% | -7.15% | 0.12% | 113/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 28.78% | -13.99% | 3.23% | 109/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 27.88% | -17.13% | -6.34% | 115/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 29.77% | -12.17% | -4.08% | 108/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 31.04% | -11.41% | -7.26% | 110/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 33.47% | 5.06% | -0.53% | 102/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 33.65% | 11.66% | -0.74% | 110/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 33.9% | 19.77% | -3.25% | 103/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 35.03% | 15.64% | 9.98% | 105/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 31.86% | 2.71% | 5.73% | 99/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 30.13% | -27.77% | 6.47% | 115/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 28.3% | -35.3% | -6.59% | 101/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 30.3% | -30.96% | -2.32% | 109/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 31.02% | -13.22% | -25.65% | 90/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 41.72% | 23.11% | -4.64% | 108/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 43.75% | 30.95% | -0.31% | 72/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 43.88% | 35.62% | 22.78% | 90/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 35.74% | 11.96% | 5.48% | 63/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 33.88% | 7.97% | 1.43% | 101/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 33.41% | 12% | 3.24% | 55/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 32.36% | -5.76% | 1.36% | 64/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 31.92% | 2% | 1.72% | 46/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 31.38% | -7.49% | 5.21% | 97/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 29.83% | 2% | -12.07% | 46/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2017-12-31 | 33.92% | -4.86% | -1.2% | 86/141 | 56.1% | 正海生物 | 92.44% | 行业排名> |
| 2017-06-30 | 34.33% | 2% | -3.71% | 47/141 | 54.85% | 正海生物 | 92.7% | 行业排名> |
| 2016-12-31 | 35.65% | 2% | 2% | 65/141 | 57.35% | 正海生物 | 93.67% | 行业排名> |